Short- and mid-term efficacy of percutaneous ethanol injection in cystic and predominantly cystic thyroid nodules: systematic review and meta-analysis
6 affiliations
- 1Division of Endocrinology and Diabetes, Department of Surgical Sciences, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, 00133 Italy
- 2School of Applied Medical‑Surgical Sciences, University of Rome Tor Vergata, Rome, 00133 Italy
- 3UO Endocrinologia, Diabetologia e Malattie del metabolismo, AO Ordine Mauriziano, Torino, 101128 Italy
- 4Department of Medicine and Surgery, Kore University of Enna, Enna, Italy
- 5Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland
- 6Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Abstract
Objective: To evaluate the short- and mid-term volume reduction rate(VRR) after percutaneous ethanol injection(PEI), at 1,3 and 6 months, in patients with cystic or predominantly cystic thyroid nodules(CNs/pCNs, respectively), conducting a systematic review and meta-analysis of published data on VRR outcomes across these intervals.
Design and methods: A systematic search of articles published up to October 30,2025 identified studies reporting PEI treatment for CNs/pCNs.Characteristics of the study design, CNs/pCNs cohorts, and outcomes of interest(VRR at 1,3 and 6 months of follow up)were extracted.Statistical analysis included a random-effects meta-analysis, assessment of heterogeneity with use of the I2 statistic, and meta-regression and subgroup analyses to explore potential sources of heterogeneity.
Results: Six studies comprising 431 CNs/pCNs were included.The pooled VRRs at 1,3 and 6 months post-PEI were 85.18%(95% CI: 80.72–89.64),91.50%(95% CI: 88.88–94.12) and 93.11%(95% CI: 90.91–95.31),respectively. Stratifying by nodule cystic composition, the VRR at consecutive follow-up time points was significantly different between the 1- and 3-month intervals in both subgroups [CN: VRRs at 1, 3 and 6 months were 91.16% (88.38–93.93), 95.69% (94.16–97.22) and 96.02% (94.16–97.87), respectively; pCN: VRRs at 1,3 and 6 months were respectively 80.19% (77.04–83.33), 87.08% (84.95–89.2) and 90.01%(88.83–91.19)].A secondary meta-regression analysis with baseline mean volume as covariate demonstrated a significant inverse association with VRR at 1 and 3 months in pCN(p = 0.02).
Conclusion: By providing pooled VRRs for the short- and mid-term follow-up, this meta-analysis should be regarded as an initial step, paving the way for larger, high-quality studies aimed at standardizing the PEI procedure and supporting its incorporation into future dedicated guidelines.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s40618-026-02927-y.
Related
- Dietary context and ethanol-related injury in preclinical models: A contemporary systematic review of predominantly obesogenic diets and liver outcomes
- Safety and efficacy of combined ethanol and bleomycin sclerotherapy via percutaneous pigtail catheter for benign cervical cystic lesions: a single-center retrospective study
- Computed tomography-guided percutaneous puncture injection of methylene blue mixed with autologous blood for preoperative localization of pulmonary nodules: analysis of 407 cases
- Successful balloon-assisted percutaneous thrombin injection for common femoral artery pseudoaneurysm after venoarterial extracorporeal membrane oxygenation decannulation.
- Efficacy of a Limosilactobacillus reuteri DSM 17938 and BG-R46® Formulation in Predominantly Breastfed Infants with Infant Distress Syndrome: A Randomized Double-Blind Placebo-Controlled Trial
BibTeX
@article{sellasie2026short,
title = {{Short- and mid-term efficacy of percutaneous ethanol injection in cystic and predominantly cystic thyroid nodules: systematic review and meta-analysis}},
author = {Sium Wolde Sellasie and Maurilio Deandrea and Stefano Amendola and Tommaso Piticchio and Luigi Uccioli and Pierpaolo Trimboli},
journal = {Journal of Endocrinological Investigation},
year = {2026},
month = jun,
doi = {10.1007/s40618-026-02927-y},
url = {https://doi.org/10.1007/s40618-026-02927-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Short- and mid-term efficacy of percutaneous ethanol injection in cystic and predominantly cystic thyroid nodules: systematic review and meta-analysis
AU - Sium Wolde Sellasie
AU - Maurilio Deandrea
AU - Stefano Amendola
AU - Tommaso Piticchio
AU - Luigi Uccioli
AU - Pierpaolo Trimboli
PY - 2026
DA - 2026/06/16
JO - Journal of Endocrinological Investigation
DO - 10.1007/s40618-026-02927-y
UR - https://doi.org/10.1007/s40618-026-02927-y
AB - Objective: To evaluate the short- and mid-term volume reduction rate(VRR) after percutaneous ethanol injection(PEI), at 1,3 and 6 months, in patients with cystic or predominantly cystic thyroid nodules(CNs/pCNs, respectively), conducting a systematic review and meta-analysis of published data on VRR outcomes across these intervals. Design and methods: A systematic search of articles published up to October 30,2025 identified studies reporting PEI treatment for CNs/pCNs.Characteristics of the study design, CNs/pCNs cohorts, and outcomes of interest(VRR at 1,3 and 6 months of follow up)were extracted.Statistical analysis included a random-effects meta-analysis, assessment of heterogeneity with use of the I2 statistic, and meta-regression and subgroup analyses to explore potential sources of heterogeneity. Results: Six studies comprising 431 CNs/pCNs were included.The pooled VRRs at 1,3 and 6 months post-PEI were 85.18%(95% CI: 80.72–89.64),91.50%(95% CI: 88.88–94.12) and 93.11%(95% CI: 90.91–95.31),respectively. Stratifying by nodule cystic composition, the VRR at consecutive follow-up time points was significantly different between the 1- and 3-month intervals in both subgroups [CN: VRRs at 1, 3 and 6 months were 91.16% (88.38–93.93), 95.69% (94.16–97.22) and 96.02% (94.16–97.87), respectively; pCN: VRRs at 1,3 and 6 months were respectively 80.19% (77.04–83.33), 87.08% (84.95–89.2) and 90.01%(88.83–91.19)].A secondary meta-regression analysis with baseline mean volume as covariate demonstrated a significant inverse association with VRR at 1 and 3 months in pCN(p = 0.02). Conclusion: By providing pooled VRRs for the short- and mid-term follow-up, this meta-analysis should be regarded as an initial step, paving the way for larger, high-quality studies aimed at standardizing the PEI procedure and supporting its incorporation into future dedicated guidelines. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s40618-026-02927-y.
SN - 0391-4097
SN - 1720-8386
ER -